Geovax Labs Stock Alpha and Beta Analysis

GOVX Stock  USD 2.64  0.07  2.58%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GeoVax Labs. It also helps investors analyze the systematic and unsystematic risks associated with investing in GeoVax Labs over a specified time horizon. Remember, high GeoVax Labs' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GeoVax Labs' market risk premium analysis include:
Beta
1.87
Alpha
(0.79)
Risk
10.24
Sharpe Ratio
(0.04)
Expected Return
(0.40)
Please note that although GeoVax Labs alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, GeoVax Labs did 0.79  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of GeoVax Labs stock's relative risk over its benchmark. GeoVax Labs has a beta of 1.87  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GeoVax Labs will likely underperform. At this time, GeoVax Labs' Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 2.38 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.29) in 2024.

Enterprise Value

6.95 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out GeoVax Labs Backtesting, GeoVax Labs Valuation, GeoVax Labs Correlation, GeoVax Labs Hype Analysis, GeoVax Labs Volatility, GeoVax Labs History and analyze GeoVax Labs Performance.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

GeoVax Labs Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GeoVax Labs market risk premium is the additional return an investor will receive from holding GeoVax Labs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GeoVax Labs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GeoVax Labs' performance over market.
α-0.79   β1.87

GeoVax Labs expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GeoVax Labs' Buy-and-hold return. Our buy-and-hold chart shows how GeoVax Labs performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

GeoVax Labs Market Price Analysis

Market price analysis indicators help investors to evaluate how GeoVax Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeoVax Labs shares will generate the highest return on investment. By understating and applying GeoVax Labs stock market price indicators, traders can identify GeoVax Labs position entry and exit signals to maximize returns.

GeoVax Labs Return and Market Media

The median price of GeoVax Labs for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 2.61 with a coefficient of variation of 28.35. The daily time series for the period is distributed with a sample standard deviation of 0.75, arithmetic mean of 2.64, and mean deviation of 0.55. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
GeoVax Labs inks sales agreement, may offer stock - Investing.com
09/25/2024
2
Geovax Labs Inc Q2 2024 Earnings Call Highlights Strategic Advances Amid Financial ...
10/09/2024
3
Acquisition by Reynolds Mark of 128000 shares of GeoVax Labs at 2.79 subject to Rule 16b-3
10/18/2024
4
GeoVax GAAP EPS of -0.91 beats by 0.57, revenue of 2.79M beats by 1.87M
11/12/2024
5
Geovax Labs Inc Q3 2024 Earnings Call Highlights Strategic Advances and Financial Challenges
11/13/2024
6
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine ...
11/19/2024
7
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
11/26/2024

About GeoVax Labs Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GeoVax or other stocks. Alpha measures the amount that position in GeoVax Labs has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Graham Number16.7922.8523.99
Receivables Turnover7.869.0316.17

GeoVax Labs Upcoming Company Events

As portrayed in its financial statements, the presentation of GeoVax Labs' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GeoVax Labs' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of GeoVax Labs' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of GeoVax Labs. Please utilize our Beneish M Score to check the likelihood of GeoVax Labs' management manipulating its earnings.
28th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with GeoVax Labs

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.